Home
Conditions
Immunologic Deficiency Syndromes

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,124 public trials 392 recruiting studies

Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Recruiting

A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection

NCT05328765

Conditions: Anal Squamous Cell Carcinoma, Anus Diseases, Anus Neoplasms, +25 more
Locations: A.C. Camargo Cancer Center São Paulo, Brazil

View Trial Details

Recruiting

COVID-19 in PID Survey

NCT04459689

Conditions: COVID, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +4 more
Locations: Imagine Institute Paris, France

View Trial Details

Recruiting

Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases

NCT00874783

Conditions: Alzheimer Disease, Amyotrophic Lateral Sclerosis, Ataxia, +60 more
Locations: Hadassah Ein Kerem Jerusalem, Israel

View Trial Details

Recruiting

Tools to Identify People At Risk or Already Infected with HIV and HCV

NCT06528626

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +16 more
Locations: Maria J. Vivancos-Gallego Madrid, Spain

View Trial Details

Recruiting

Observational Pharmaco-Epidemiology Research & Analysis

NCT03813862

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Cardiovascular Diseases, +31 more
Locations: Epividian Durham, North Carolina, United States

View Trial Details

Recruiting

Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein

NCT06441123

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: CHU de MONTPELLIER Montpellier, France

View Trial Details

Recruiting

Use of Long-Acting Injectable Cabotegravir/Rilpivirine for the Treatment of HIV in Belgium

NCT06424964

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Saint-Pierre University Hospital Brussels, Belgium

View Trial Details

Recruiting

PrEPared to Choose (PtC) is an Implementation Study of the Delivery of Cabotegravir Long-acting, an Injectable Pre-exposure Prophylaxis (PrEP) Option for HIV Prevention. Injectable PrEP Will be Offered Alongside Oral and Vaginal Ring PrEP From Within a Real-world Context in Cape Town, South Africa.

NCT06807736

Conditions: Behavior, Blood-Borne Infections, Coitus, +16 more
Locations: Desmond Tutu Health Foundation Cape Town, Western Province, South Africa

View Trial Details

Recruiting

HIV and Changes in the Gut Microbiome After Changes in Antiretroviral Therapy (ART)

NCT06100211

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Manchester University NHS Foundation Trust Manchester, Greater Manchester, United Kingdom

View Trial Details

Recruiting

Accurate Staging of Immuno-virological Dynamics During Acute HIV Infection

NCT03449706

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +14 more
Locations: UZ Gent Ghent, Oost-Vlaanderen, Belgium

View Trial Details

Immunologic Deficiency Syndromes

Immunologic Deficiency Syndromes trial results

Related conditions